Background. Systemic Lupus Erythematosus (SLE) is a chronic multisystem autoimmune disease characterized by the production of autoantibodies and excessive immune activation, resulting in widespread organ damage. Immunosuppressive therapy constitutes a cornerstone in the management of SLE by suppressing abnormal immune responses and preventing further organ injury. The effectiveness of such ther…